Nano-X Imaging CEO buys 25,000 shares at $0.45

Nano-X Imaging's chief executive officer also held three direct option positions, with one tranche scheduled to become fully vested on April 16, 2028.

Rhea-AI Filing Summary

Nano-X Imaging Ltd. (NNOX) CEO and director Erez Meltzer indirectly purchased 25,000 ordinary shares on October 19, 2026, at $0.45 per share through Oud Nof, a company wholly owned by him. Oud Nof held 90,443 shares after the purchase. No Rule 10b5-1 plan is reported. The report separately lists 60,584 ordinary shares held directly as of October 19, 2026, and three direct option positions.

Insider Trade Summary

Net Buyer: 25,000 shares

Net Buy 5 txns

Insider Meltzer Erez

Role Chief Executive Officer

Bought 25,000 shs ($11K)

Type	Security	Shares	Price	Value
Purchase	Ordinary Shares F1	25,000	$0.45	$11K
holding	Stock Option (right to buy ordinary shares) F2, F3	--	--	--
holding	Stock Option (right to buy ordinary shares) F2, F4	--	--	--
holding	Stock Option (right to buy ordinary shares) F2, F5	--	--	--
holding	Ordinary Shares F2	--	--	--

Holdings After Transaction: Ordinary Shares — 90,443 shares (Indirect, By a wholly owned company); Stock Option (right to buy ordinary shares) — 490,234 contracts (Direct); Ordinary Shares — 60,584 shares (Direct)

Footnotes (5)

1. F1. The ordinary shares reported in this row were purchased by Oud Nof, a company wholly owned by the Reporting Person.
2. F2. There were no transactions effected in respect of the securities reported in this row, and the holdings in this row are being included for informational purposes only.
3. F3. The options reported in this row were granted to the Reporting Person by the Issuer on February 11, 2020 and are fully vested and exercisable as of the date of this report.
4. F4. The options reported in this row were granted to the Reporting Person by the Issuer on January 2, 2020 and are fully vested and exercisable as of the date of this report.
5. F5. The options reported in this row were granted to the Reporting Person by the Issuer on April 16, 2024, and vest and become exercisable in accordance with the following schedule: 25% of the options vested upon the one-year anniversary of the grant, and an additional 6.25% of the options vest on a quarterly basis over the following three years such that all options reported in this row will be fully vested on the four-year anniversary of that grant date (April 16, 2028).

Key Figures

Ordinary shares purchased: 25,000 shares Purchase price: $0.45 per share Indirect ordinary shares held after purchase: 90,443 shares +4 more

7 metrics

Ordinary shares purchased 25,000 shares Purchased through Oud Nof on October 19, 2026

Purchase price $0.45 per share Purchase on October 19, 2026

Indirect ordinary shares held after purchase 90,443 shares Held by Oud Nof

Direct ordinary shares held 60,584 shares As of October 19, 2026

Direct options—underlying ordinary shares 40,234 shares at $2.21 per share exercise price Expires February 11, 2030; fully vested and exercisable

Direct options—underlying ordinary shares 300,000 shares at $23.84 per share exercise price Expires January 2, 2032; fully vested and exercisable

Direct options—underlying ordinary shares 150,000 shares at $11.52 per share exercise price Expires April 16, 2034; scheduled to be fully vested on April 16, 2028

Key Terms

wholly owned company, Stock Option (right to buy ordinary shares), fully vested and exercisable, vest and become exercisable

4 terms

wholly owned company financial

"a company wholly owned by the Reporting Person"

Stock Option (right to buy ordinary shares) financial

"Stock Option (right to buy ordinary shares)"

fully vested and exercisable financial

"are fully vested and exercisable as of the date of this report"

vest and become exercisable financial

"vest and become exercisable in accordance with the following schedule"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many NNOX shares did CEO Erez Meltzer buy?

Oud Nof, a company wholly owned by NNOX CEO and director Erez Meltzer, purchased 25,000 ordinary shares on October 19, 2026, at $0.45 per share. Oud Nof held 90,443 shares after the purchase. No Rule 10b5-1 plan is reported.

What options does NNOX CEO Erez Meltzer hold?

The report lists three direct option positions: 40,234 ordinary shares at a $2.21 exercise price, expiring February 11, 2030; 300,000 shares at $23.84, expiring January 2, 2032; and 150,000 shares at $11.52, expiring April 16, 2034. The first two grants were fully vested and exercisable; the third is scheduled to be fully vested on April 16, 2028.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 10/20/2026 - 06:04 AM EDT Accepted by SEC EDGAR 10/20/2026 - 06:01 AM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Meltzer Erez

(Last) (First) (Middle)

C/O NANO-X IMAGING LTD., OFER TECH PARK

94 SHLOMO SHMELTZER ROAD

(Street)

PETACH TIKVA 4970602

(City) (State) (Zip)

ISRAEL

(Country)

2. Issuer Name and Ticker or Trading Symbol
Nano-X Imaging Ltd. [ NNOX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
10/19/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares	10/19/2026		P		25,000	A	$0.45	90,443	I	By a wholly owned company(1)
Ordinary Shares(2)								60,584	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to buy ordinary shares)(2)	$2.21							(3)	02/11/2030	Ordinary Shares	40,234		40,234	D
Stock Option (right to buy ordinary shares)(2)	$23.84							(4)	01/02/2032	Ordinary Shares	300,000		300,000	D
Stock Option (right to buy ordinary shares)(2)	$11.52							(5)	04/16/2034	Ordinary Shares	150,000		150,000	D

Explanation of Responses:

1. The ordinary shares reported in this row were purchased by Oud Nof, a company wholly owned by the Reporting Person.

2. There were no transactions effected in respect of the securities reported in this row, and the holdings in this row are being included for informational purposes only.

3. The options reported in this row were granted to the Reporting Person by the Issuer on February 11, 2020 and are fully vested and exercisable as of the date of this report.

4. The options reported in this row were granted to the Reporting Person by the Issuer on January 2, 2020 and are fully vested and exercisable as of the date of this report.

5. The options reported in this row were granted to the Reporting Person by the Issuer on April 16, 2024, and vest and become exercisable in accordance with the following schedule: 25% of the options vested upon the one-year anniversary of the grant, and an additional 6.25% of the options vest on a quarterly basis over the following three years such that all options reported in this row will be fully vested on the four-year anniversary of that grant date (April 16, 2028).

Remarks:

See Exhibit 24.1: Power of Attorney

	/s/ Marina Gofman Feler, attorney-in-fact	10/20/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)